Laure Marignol received a double BSc from the University of Montpellier (France) and the Fachhochschule Giessen (Germany), an Msc from University College London, and a PhD from Trinity. She joined the School of Medicine as a lecturer in 2008 and is now assistant professor in the Discipline of Radiation Therapy, and the principal investigator of Radiobiology and Molecular Oncology research within the Applied Radiation Therapy Trinity, Trinity College Dublin. Laure has developed a specific interest and research track record in the area of hypoxia and its influence on radiation sensitivity. In 2012, she was awarded a very competitive Prostate Cancer Research Project award from the Irish Cancer Society in to investigate the prognostic potential of miRNAs in high risk prostate cancer patients. Over 400 Irish men per year and 180,000 worldwide are affected by their cancer coming back after their radiotherapy treatment. Her research aims to generate new prognostic algorithms that detect patients at high risk of failure following radiation therapy, and design new therapeutic options that prevent tumour regrowth after radiotherapy.